Evaluation of Tonabersat for DME

Running, not enrolling · Phase 2 · Has a placebo group

Conditions studied: Diabetic Macular Edema

In brief

This randomized clinical trial will evaluate the effect of tonabersat compared with placebo on central subfield thickness (CST) in eyes with center-involved diabetic macular edema (CI-DME) and good visual acuity.

Key facts

Study ID
NCT05727891
Run by
Jaeb Center for Health Research
People needed
128
Starts
2023-05-02
Expected to finish
2026-01-01
Last updated by the study team
2025-12-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.